Hypothyroidism Pipeline Review: H1 2018, Covering Key Players Diurnal Group, Synthonics and Titan Pharmaceuticals - ResearchAndMarkets.com

DUBLIN--()--The "Hypothyroidism - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

The Hypothyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase III and Preclinical stages are 1 and 4 respectively.

Hypothyroidism (Hormonal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Companies Mentioned

  • Diurnal Group Plc
  • Synthonics Inc
  • Titan Pharmaceuticals Inc

Key Topics Covered

  1. Introduction
  2. Report Coverage
  3. Hypothyroidism - Overview
  4. Hypothyroidism - Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Products under Development by Companies
  8. Hypothyroidism - Therapeutics Assessment
  9. Assessment by Target
  10. Assessment by Mechanism of Action
  11. Assessment by Route of Administration
  12. Assessment by Molecule Type
  13. Hypothyroidism - Companies Involved in Therapeutics Development
  14. Diurnal Group Plc
  15. Synthonics Inc
  16. Titan Pharmaceuticals Inc
  17. Hypothyroidism - Drug Profiles
  18. Hypothyroidism - Dormant Projects
  19. Hypothyroidism - Product Development Milestones
  20. Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/research/ch5sjh/hypothyroidism?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs